Nelson Labs facility expansion to benefit parenteral and ophthalmic drug product manufacturers
European Pharmaceutical Review
FEBRUARY 15, 2024
The investment expands the site to over 30,000ft 2 and includes state-of-the-art instrumentation to provide full CMC support to serve the growth of PODP product customers who require the highest levels of safety, sterility, and stability.
Let's personalize your content